01143nam0 22003013i 450 PUV109359520231121125621.0887503061820160331d2007 ||||0itac50 baitaitz01i xxxe z01nPredizione e incertezzala diffusione dei test genetici nella pratica clinicainserto a cura della Commissione bioetica della Tavola ValdesePiacenzaVicolo del Pavone200787 p.21 cmTit. in cop.A.15, 1 (mar. 2007)CFI0241245001CFI02412452001 Bioeticarivista interdisciplinareTavola valdese : Commissione bioeticaPUVV377411ITIT-0120160331IT-FR0017 Biblioteca umanistica Giorgio ApreaFR0017 PUV1093595Biblioteca umanistica Giorgio Aprea 52CIS Per.it.159 Suppl.1 52VM 0000696715 VM barcode:00061078VMA 2007062520121204 52Predizione e incertezza3614814UNICAS03878nam 2200697Ia 450 991095669650332120200520144314.09786611321697978128132169512813216999780470760154047076015X97804707598820470759887(CKB)1000000000415500(EBL)351355(OCoLC)781319108(SSID)ssj0000224618(PQKBManifestationID)11210505(PQKBTitleCode)TC0000224618(PQKBWorkID)10210796(PQKB)10243307(MiAaPQ)EBC351355(Au-PeEL)EBL351355(CaPaEBR)ebr10232799(CaONFJC)MIL132169(Perlego)2773594(EXLCZ)99100000000041550020000823d2001 uy 0engur|n|---|||||txtccrPortal hypertension III proceedings of the Third Baverno International Consensus Workshop on Definitions, Methodology, and Therapeutic Strategies /edited by Roberto De Franchis3rd ed.Oxford ;Malden, MA Blackwell Science20011 online resource (270 p.)Description based upon print version of record.9780632059188 0632059184 Includes bibliographical references and index.Portal Hypertension III; Contents; Contributors; Preface; Lecture What Have We Accomplished?; Session 1 Definition of Key Events: Let's Try Again; BAVENO III CONSENSUS STATEMENTS; Lecture Stellate Cells: Do They Have a Role in Portal Hypertension?; Session 2 Diagnosis of Portal Hypertension: How and When; BAVENO III CONSENSUS STATEMENTS; Session 3A Portal Hypertensive Gastropathy; Session 3B Gastric Varices; BAVENO III CONSENSUS STATEMENTS; Session 4 Preprimary Prophylaxis. Can (and Should) We Prevent the Formation and Growth of Varices; BAVENO III CONSENSUS STATEMENTSLecture Antifibrotic Therapy: Future Cure for Portal Hypertension?Session 5 Primary Prophylaxis; BAVENO III CONSENSUS STATEMENTS; Session 6 Treatment of the Acute Bleeding Episode; BAVENO III CONSENSUS STATEMENTS; Session 7 Prevention of Recurrent Variceal Haemorrhage (Secondary Prophylaxis); BAVENO III CONSENSUS STATEMENTS; Session 8 Complications in the Medical Treatment of Portal Hypertension; BAVENO III CONSENSUS STATEMENTS; Lecture Quality of Randomized Clinical Trials in Portal Hypertension and Other Fields of HepatologySession 9 Methodology of Future Trials: Prognostic Stratification, Health-Related Quality of Life and Health EconomicsBAVENO III CONSENSUS STATEMENTS; IndexProceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. The participants attempted to develop consensus definitions of key events in portal hypertension and variceal bleeding, diagnostic and therapeutic issues, and the complications of therapies for portal hypertension, as well as producing updated guidelines. The lectures summarized the consensus reached in the earlier workshops, addressed two important new areas of research, and analyzed the quality of trials in portal hypertension and other fields of hepatology.Portal hypertension 3Portal hypertension threePortal hypertensionCongressesHypertensionCongressesPortal hypertensionHypertension616.3/62De Franchis Roberto855338MiAaPQMiAaPQMiAaPQBOOK9910956696503321Portal hypertension III2139944UNINA